Name | Number of supported studies | Average coverage | |
---|---|---|---|
astrocyte | 13 studies | 47% ± 20% | |
oligodendrocyte | 5 studies | 22% ± 3% |
Insufficient scRNA-seq data for expression of ACSBG1 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
brain | 98% | 3464.68 | 2602 / 2642 | 99% | 17.87 | 695 / 705 |
skin | 69% | 1846.65 | 1245 / 1809 | 39% | 2.33 | 185 / 472 |
ureter | 0% | 0 | 0 / 0 | 100% | 1.69 | 1 / 1 |
adrenal gland | 45% | 350.07 | 115 / 258 | 8% | 0.28 | 19 / 230 |
eye | 0% | 0 | 0 / 0 | 38% | 1.45 | 30 / 80 |
bladder | 0% | 0 | 0 / 21 | 16% | 0.79 | 82 / 504 |
intestine | 14% | 66.67 | 137 / 966 | 0% | 0.00 | 1 / 527 |
prostate | 10% | 53.56 | 24 / 245 | 2% | 0.04 | 9 / 502 |
thymus | 0% | 0 | 0 / 653 | 10% | 0.37 | 59 / 605 |
lung | 5% | 23.82 | 30 / 578 | 3% | 0.10 | 40 / 1155 |
uterus | 2% | 7.87 | 3 / 170 | 6% | 0.36 | 29 / 459 |
esophagus | 2% | 9.11 | 33 / 1445 | 2% | 0.04 | 3 / 183 |
kidney | 0% | 0 | 0 / 89 | 4% | 0.22 | 35 / 901 |
lymph node | 0% | 0 | 0 / 0 | 3% | 0.10 | 1 / 29 |
stomach | 2% | 7.61 | 7 / 359 | 1% | 0.03 | 4 / 286 |
heart | 3% | 9.74 | 23 / 861 | 0% | 0 | 0 / 0 |
breast | 0% | 2.40 | 2 / 459 | 1% | 0.10 | 13 / 1118 |
liver | 0% | 0 | 0 / 226 | 1% | 0.08 | 6 / 406 |
ovary | 0% | 0 | 0 / 180 | 1% | 0.04 | 6 / 430 |
pancreas | 0% | 0 | 0 / 328 | 1% | 0.06 | 2 / 178 |
peripheral blood | 1% | 3.91 | 7 / 929 | 0% | 0 | 0 / 0 |
adipose | 0% | 0.77 | 2 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 0% | 0.35 | 1 / 1335 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
muscle | 0% | 0 | 0 / 803 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spleen | 0% | 0 | 0 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 45 |
GO_0042759 | Biological process | long-chain fatty acid biosynthetic process |
GO_0051384 | Biological process | response to glucocorticoid |
GO_0000038 | Biological process | very long-chain fatty acid metabolic process |
GO_0001676 | Biological process | long-chain fatty acid metabolic process |
GO_0042552 | Biological process | myelination |
GO_0035338 | Biological process | long-chain fatty-acyl-CoA biosynthetic process |
GO_0005783 | Cellular component | endoplasmic reticulum |
GO_0005829 | Cellular component | cytosol |
GO_0005886 | Cellular component | plasma membrane |
GO_0031410 | Cellular component | cytoplasmic vesicle |
GO_0005737 | Cellular component | cytoplasm |
GO_0004467 | Molecular function | long-chain fatty acid-CoA ligase activity |
GO_0005524 | Molecular function | ATP binding |
GO_0031957 | Molecular function | very long-chain fatty acid-CoA ligase activity |
Gene name | ACSBG1 |
Protein name | Long-chain-fatty-acid--CoA ligase ACSBG1 (EC 6.2.1.3) (Acyl-CoA synthetase bubblegum family member 1) Acyl-CoA synthetase bubblegum family member 1 long-chain-fatty-acid--CoA ligase (EC 6.2.1.3) Long-chain-fatty-acid--CoA ligase ACSBG1 (EC 6.2.1.3) (Acyl-CoA synthetase bubblegum family member 1) (hBG1) (hsBG) (hsBGM) (Lipidosin) |
Synonyms | KIAA0631 LPD BGM |
Description | FUNCTION: Catalyzes the conversion of fatty acids such as long-chain and very long-chain fatty acids to their active form acyl-CoAs for both synthesis of cellular lipids, and degradation via beta-oxidation . Can activate diverse saturated, monosaturated and polyunsaturated fatty acids . . |
Accessions | ENST00000560124.5 Q96GR2 ENST00000557935.1 ENST00000559707.5 H0YMC3 H0YMH2 H0YMZ0 ENST00000559114.5 ENST00000258873.9 ENST00000558130.1 H0YM34 H0YMF5 ENST00000559241.5 H0YNX0 F5H4U6 ENST00000560817.5 |